Literature DB >> 29363232

Relevant obstetric factors associated with fetal heart rate monitoring for cerebral palsy in pregnant women with hypertensive disorder of pregnancy.

Junichi Hasegawa1, Tomoaki Ikeda2, Satoshi Toyokawa3, Emi Jojima4, Shoji Satoh5, Kiyotake Ichizuka6, Nanako Tamiya7, Akihito Nakai8, Keiya Fujimori9, Tsugio Maeda10, Hideaki Masuzaki11, Satoru Takeda12, Hideaki Suzuki4, Shigeru Ueda4, Tsuyomu Ikenoue13.   

Abstract

AIM: The study identifies the relevant obstetric factors associated with fetal heart rate (FHR) monitoring for cerebral palsy (CP) in pregnant women with hypertensive disorders of pregnancy (HDP).
METHODS: The subjects were neonates with CP (birth weight ≥ 2000 g, gestational age ≥ 33 weeks) who were approved for compensation for CP by the Operating Organization of the Japan Obstetric Compensation System between 2009 and 2012. After selection of women with antepartum HDP, obstetric characteristics associated with FHR monitoring were analyzed.
RESULTS: The subjects included 33 neonates with CP whose mothers suffered from HDP during pregnancy and 450 neonates whose mothers did not develop HDP. The rates of placental abruption (48.5% vs. 20%; P < 0.001) and light-for-gestational age (12.1% vs. 2.2%; P = 0.011) were significantly higher in women with HDP than in those without HDP. Regarding FHR pattern analysis, fetal bradycardia was observed on admission to hospital in 94% of women with placental abruption. In women without placental abruption, FHR was likely to indicate a favorable pattern on admission, but became worse with the progression of labor.
CONCLUSION: This is first study to clinically demonstrate FHR patterns in CP cases in association with HDP. Although antepartum CP is undetectable, pregnant women with HDP should be placed under strict observation and management to minimize fetal hypoxic conditions during labor.
© 2018 The Authors. Journal of Obstetrics and Gynaecology Research published by John Wiley & Sons Australia, Ltd on behalf of Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  cerebral palsy; fetal heart rate; hypertension; hypertensive disorder of pregnancy; hypoxia; placental abruption

Mesh:

Year:  2018        PMID: 29363232      PMCID: PMC5900742          DOI: 10.1111/jog.13555

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


Introduction

Cerebral palsy (CP) is a physical disability that occurs in children. CP is associated with neonatal hypoxia and acidemia involved with non‐reassuring fetal status during labor as a result of placental and umbilical cord abnormalities (placental abruption and umbilical cord prolapse).1 The pathophysiology of hypertensive disorders of pregnancy (HDP) is complex and involves multiple organ systems. In this disorder, increasing resistance of maternal systemic blood vessels adversely affect blood flow, not only in maternal organ systems, but also the placenta, resulting in both maternal and neonatal pathologic conditions.2, 3, 4 Therefore, identifying the clinical course and obstetric factors of CP associated with HDP could be important for making recommendations for the management of HDP and reducing the rate of CP. The present study aimed to identify the relevant obstetric factors associated with fetal heart rate (FHR) pattern for CP in pregnant women with HDP.

Methods

The details of the Japan Obstetric Compensation System for Cerebral Palsy (JOCSC) have been described in our previous report. 1 The JOCSC was launched in January 2009 to provide prompt no‐fault compensation for children diagnosed with severe CP associated with obstetric factors and for their respective families. The JOCSC also provides information that could help in prevention, early resolution of disputes and improvement in the quality of obstetric health care. A case review for compensation is performed by a review committee. After a child is declared eligible to receive compensation by this review committee, the causes for CP are analyzed individually by the Causal Analysis Committee, which consists of obstetricians, pediatricians, midwives and lawyers. Once collected, the Recurrence Prevention Committee analyzes these individual cases from an epidemiological standpoint. The subjects of the current study were neonates with CP who were approved for compensation by a review of the Operating Organization of JOCSC. All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The Institutional Review Boards of the JOCSC approved the study. Written informed consent was not obtained from the patients; however, they were provided with a supplemental file announcing the implementation of a ‘case‐control study of cerebral palsy and prevention of its recurrence’. Although the analysis was retrospective, data from the anonymized JOCSC database were collected in a normal clinical setting and the confidentiality of the patients involved was protected. All patient records/information was de‐identified prior to analysis. Criteria for inclusion in the present study were as follows: neonates born between January 2009 and December 2012; with a birth weight of ≥ 2000 g, and gestational age ≥ 33 weeks; and with severe disability resulting from CP independent of congenital causes or factors during the neonatal period or later, with disability certified to be of first or second‐degree severity according to the grade of disability definitions in the Welfare of Physically Disabled Persons Act. After selection of the neonates of mothers with antepartum HDP, obstetric clinical characteristics associated with FHR pattern and disease course were analyzed. Cases were subcategorized into groups with and without placental abruption and the FHR record was retrospectively analyzed for each group. We categorized cases into five different groups based on the FHR pattern at admission for labor and just before delivery according to Phelan et al. 5 The bradycardia group comprised fetuses with bradycardia or persistent severe decelerations with loss of variability at admission for labor and no recovery until delivery. The persistent non‐reassuring (NR) group comprised fetuses with non‐reactive FHR and usually decreased baseline variability at admission for labor that persisted until delivery. The reactive‐prolonged deceleration (PD) group comprised fetuses with a normal FHR pattern at admission for labor and acute severe prolonged deceleration or bradycardia before delivery. The Hon pattern group comprised fetuses with a normal FHR pattern at admission for labor. Consequently, recurrent severe decelerations with baseline heart rate increased and baseline variability decreased. Finally, terminal prolonged deceleration or bradycardia occurred before delivery. The persistent reactive group comprised fetuses with a normal FHR range during the entire course. Cerebral palsy was defined as a disturbance in motor function or posture in neonates that was permanent or variable. This disorder is based on a non‐progressive cerebral lesion that develops between conception and the neonatal period (within 4 weeks after birth). However, this definition excludes motor retardation that is either transient or normalizes in the future. The definition and classification of HDP used in this study followed the guidelines published by the Japan Society for the Study of Hypertension in Pregnancy for Japanese obstetric care providers.6 HDP was defined as hypertension (blood pressure ≥ 140/90 mmHg) with or without proteinuria (0.3 g in a 24 h urine specimen or a protein‐to‐creatinine ratio of > 0.30) emerging after 20 weeks of gestation and resolving up to 12 weeks post‐partum. Mild HDP was diagnosed when blood pressure was ≥ 140/90 mmHg, but < 160/110 mmHg after 20 weeks’ gestation, and proteinuria was ≥ 300 mg/24 h without exceeding 2.0 g/24 h or 3+ dipstick test results were observed. Severe HDP was diagnosed when blood pressure was ≥ 160/110 mmHg and proteinuria exceeded 2.0 g/24 h or a 3+ dipstick test results were observed. HDP that emerged earlier than 32 weeks’ gestation was referred to as early‐onset and HDP that emerged after 32 weeks’ gestation was referred to as late‐onset. Light‐for‐gestational age infants were diagnosed as weighing lower than the 10th percentile based on the standard of Japanese birth for the gestational period.

Statistical analysis

A two‐sided P value of 0.05 was used to define statistical significance. All analyses were conducted using stata version 13.0. Continuous variables are reported as mean ± standard deviation and were compared using Student's t or Mann–Whitney U tests. Integer variables are reported as median and range, and were compared using the Mann–Whitney U test. Categorical variables are reported as frequencies and were compared using Fisher's exact test.

Results

Four hundred and eighty‐three cases of CP from the JOCSC database were included in the study. Thirty‐three neonates with CP born from pregnant women complicated by HDP during pregnancy and 450 neonates born from pregnant women without HDP were compared. The characteristics of these subjects are shown in Table 1. Neonates born to mothers with HDP were smaller and of an earlier gestational age.
Table 1

Characteristics of the subjects

CharacteristicWith HDP (n = 33)Without HDP (n = 450) P
Maternal characteristics
Age 33.2 ± 5.4 31.1 ± 5.2 0.025
Height (cm)156.4 ± 5.5157.9 ± 5.60.119
Weight at beginning of pregnancy (kg)56.2 ± 7.453.9 ± 10.50.214
BMI (kg/m2)23.1 ± 3.121.6 ± 4.20.055
Weight at delivery (kg)66.0 ± 8.164.0 ± 10.10.267
Weight gain (kg)9.6 ± 4.610.1 ± 4.10.463
Parity (median, range)00 (0–4)00 (0–5)0.895
In vitro fertilization6.1% (2)3.6% (16)0.352
Mode of delivery
Normal spontaneous15.2% (5)28.2% (127)0.204
Instrumental12.1% (4)16.2% (73)
Elective CS3.0% (1)2.0% (9)
Emergency CS69.7% (23)53.6% (241)
Delivery at
Hospital 90.9% (30) 64.4% (290) 0.008
Small hospital with < 20 beds9.1% (3)34.7% (156)
Midwifery home0.0% (0)0.9% (4)
Maternal transport after onset of labor 18.2% (6)8.7% (39)0.110
Neonate
Multiple pregnancy6.1% (2)4.2% (19)0.647
Gestational weeks 37.4 ± 2.1 38.3 ± 1.9 0.011
Birth weight (g) 2582 ± 372 2889 ± 453 < 0.001
Birth weight (SD) −0.7 ± 0.7 −0.1 ± 1.1 0.005
Male36.4% (12)53.6% (241)0.070
Apgar score 1 min (median, range) 1 (0–8) 2 (0–10) 0.017
Apgar score 5 min (median, range) 3 (0–8) 4 (0–10) 0.016
Umbilical artery PH 6.844 ± 0.235 6.990 ± 0.269 0.015

BMI, body mass index; CS, cesarean section; HDP, hypertensive disorder of pregnancy; SD, standard deviation.

Characteristics of the subjects BMI, body mass index; CS, cesarean section; HDP, hypertensive disorder of pregnancy; SD, standard deviation. The major relevant obstetric factors for CP reviewed by the JOCSC in pregnant women with and without HDP are shown in Table 2. The rate of light‐for‐gestational age was significantly higher in children born to mothers with HDP than in those born to mothers without HDP (P = 0.011). Placental abruption was significantly in higher in children born to mothers with HDP than in those born to mothers without HDP (P < 0.001).
Table 2

Major relevant obstetric factors for cerebral palsy reviewed by the Operating Organization of the JOCSC in neonates and mothers with and without HDP

Major relevant obstetric factors for cerebral palsyWith HDP (n = 33)Without HDP (n = 450) P
Light for gestational age 4 12.1% 10 2.2% 0.011
Placental abnormalities 17 51.5% 115 25.6% 0.002
Placental abruption1648.5%9020.0% < 0.001
Placental abruption (15)(86)
Placental abruption and cord abnormality (0)(3)
Placental abruption with uterine rupture (0)(1)
Maternal shock after placental abruption (1)(0)
Bleeding of placenta previa00.0%20.4%1.000
Feto‐maternal blood transfusion00.0%143.1%0.613
Monochorionic‐diamniotic twins13.0%92.0%0.511
Umbilical cord abnormalities 2 6.1% 111 24.7% 0.011
Umbilical cord prolapse13.0%204.4%
Umbilical cord prolapse with cord abnormality00.0%10.2%
Cord abnormalities13.0%7717.1%
Cord abnormalities and infectious disease00.0%122.7%
Cord abnormalities and IVH in neonate00.0%10.2%
Maternal complications 2 6.1% 47 10.4% 0.561
Uterine rupture00.0%173.8%
Infectious disease00.0%224.9%
Maternal cardiopulmonary arrest00.0%20.4%
Amniotic fluid embolism00.0%30.7%
Eclampsia26.1%00.0%
Gestational diabetes mellitus00.0%20.4%
Diabetes mellitus00.0%10.2%
Neonatal complications 0 0.0% 10 2.2% 1.000
Blood type incompatibility00.0%10.2%
IVH00.0%30.7%
Cerebral infarct00.0%20.4%
Hypoglycemia00.0%10.2%
Tension pneumothorax00.0%10.2%
Ventricular tachycardia00.0%10.2%
Persistent pulmonary hypertension of the newborn00.0%10.2%
Other causes or unexplained 8 24.2% 157 34.9% 0.256

Umbilical cord abnormalities included velamentous or marginal cord insertion, hypercoiled cord, cord entanglement, a true knot, a single umbilical artery and umbilical cord constriction. Events associated with intervention during labor included vacuum extraction, forceps delivery, induction of labor and uterine fundal pressure.

HDP, hypertensive disorder in pregnancy; IVH, intraventricular hemorrhage; JOCSC, Japan Obstetric Compensation System for Cerebral Palsy.

Major relevant obstetric factors for cerebral palsy reviewed by the Operating Organization of the JOCSC in neonates and mothers with and without HDP Umbilical cord abnormalities included velamentous or marginal cord insertion, hypercoiled cord, cord entanglement, a true knot, a single umbilical artery and umbilical cord constriction. Events associated with intervention during labor included vacuum extraction, forceps delivery, induction of labor and uterine fundal pressure. HDP, hypertensive disorder in pregnancy; IVH, intraventricular hemorrhage; JOCSC, Japan Obstetric Compensation System for Cerebral Palsy. A summary of 16 neonates with CP after placental abruption in mothers with HDP is shown in Table 3. There were no light‐for‐gestational age infants. Severe HDP at the onset of placental abruption was observed in three (19%) women. Transfer of the mother and newborn to intensive care was required after the occurrence of placental abruption in four women because treatment was difficult in the clinic. In FHR pattern analysis, bradycardia was observed on admission to hospital in 94% (15/16) of fetuses. Most women with placental abruption underwent immediate emergency cesarean section. Only one woman had an umbilical artery pH of > 7.0.
Table 3

Summary of cases of cerebral palsy associated with placental abruption in HDP cases

CaseGA onset of HDPInitial symptom at onset of PASeverity of HDP at onset of PAGA at deliveryBW (g)(SD)Apgar scoreUApHModeInitial abnormal FHRInterval between initial abnormal FHR and deliveryInterval between decision and deliveryCategory of FHR monitoringDelivery institution
131Abdominal pain Bleeding Mild33 + 120260.10/06.61emCSOn admission01:1001:10Persistent bradycardia Hospital
230Abdominal pain during hospitalization for HDPSevere34 + 42114−0.50/06.71emCSWith abdominal pain02:0700:28Persistent bradycardia Hospital
335Abdominal pain, PROMMild35 + 42332−0.41/16.58emCSOn admission00:3500:31Persistent bradycardia Hospital
435Abdominal pain Bleeding Severe35 + 62290−0.70/0n/remCSOn admission04:1301:03Persistent bradycardia Hospital
533Onset of laborMild36 + 12148−1.36/77.01emCSOn admission03:3700:45Hon pattern Hospital
636Abdominal pain Bleeding Mild36 + 22450−0.40/0n/remCSOn admission00:1500:15Persistent bradycardia Hospital
736Abdominal pain Headache Severe36 + 52522−0.31/26.57emCSOn admission01:1801:21Persistent bradycardia Hospital
836Abdominal pain Fetal movement loss Mild36 + 52568−0.20/4n/remCSOn admission00:5700:57Persistent bradycardia Clinic‐Hospital (transport)
936Abdominal painn/r36 + 62334−1.00/26.67emCSOn admission00:3200:27Persistent bradycardia Hospital
1037Abdominal painMild37 + 32444−1.00/0n/remCSOn admission01:3801:38Persistent bradycardia Clinic‐Hospital (transport)
1135Abdominal pain, PROMMild37 + 42448−1.00/36.62emCSOn admission06:0300:11Persistent bradycardia Hospital
1238Abdominal pain Bleeding Mild38 + 12478−1.22/46.75emCSOn admission00:4800:33Persistent bradycardia Clinic
1338Abdominal pain Bleeding Mild38 + 22680−0.61/16.70NSDOn admission00:3600:36Persistent bradycardia Clinic‐Hospital (transport)
1438Abdominal pain Hypotension Mild38 + 22736−0.41/56.71emCSOn admission02:2400:35Persistent bradycardia Hospital
1536Abdominal painMild38 + 22824−0.21/2n/remCSOn admission00:5200:52Persistent bradycardia Clinic‐Hospital (transport)
1637Onset of laborMild38 + 62806−0.50/06.76VEG, UFPOn admission01:5500:11Persistent bradycardia Hospital

BW, birth weight; emCS, emergency cesarean section; FHR, fetal heart rate; GA, gestational age; HDP, hypertensive disorder of pregnancy; LD, late deceleration; NSD, normal spontaneous delivery; n/r, not reported; PA, placental abruption; PD, prolonged deceleration; SD, standard deviation; UApH, umbilical artery pH; UFP, uterine fundal pressure; VEG, vacuum extraction.

Summary of cases of cerebral palsy associated with placental abruption in HDP cases BW, birth weight; emCS, emergency cesarean section; FHR, fetal heart rate; GA, gestational age; HDP, hypertensive disorder of pregnancy; LD, late deceleration; NSD, normal spontaneous delivery; n/r, not reported; PA, placental abruption; PD, prolonged deceleration; SD, standard deviation; UApH, umbilical artery pH; UFP, uterine fundal pressure; VEG, vacuum extraction. A summary of 11 cases of CP without placental abruption in mothers with HDP is shown in Table 4. Five of these 11 (45%) neonates were light‐for‐gestational age. FHR pattern analysis showed that the reassuring pattern was noted on admission, including reactive‐PD, Hon pattern and persisting reassuring in 64% (7/11) of fetuses. However, they were considered to have suffered asphyxia during labor, resulting in CP, because prolonged deceleration or the Hon pattern of FHR was observed before delivery, except in cases of monochorionic diamniotic twins. The reactive‐PD group was associated with umbilical cord prolapse, vasa previa, light‐for‐gestational age and eclampsia.
Table 4

Summary of cases of cerebral palsy without placental abruption in HDP cases

CaseGA onset of HDPGA at admissionCause of admissionSeverity of HDP on admissionGA at deliveryBW (g)(SD)ApgarUApHMode (indication)Onset of abnormal FHRInterval between initial FHR abnormality and deliveryInterval between decision and deliveryCategory of FHR monitoringFinal Causation of cerebral palsyDelivery institution
13333HDPSevere34 + 223100.43/67.09Elective CS (MD twin, GH)Non/aElective CSPersistent reassuringMonochorionic‐diamniotic twin Hospital
23335HDPSevere35 + 42009−1.54/57.00emCS (NRFS)On admission32:3202:50Persistent NRLight for gestational age Hospital
33436Headache, stomachache and HDPSevere37 + 02095−1.94/46.64NSDOn admission14:43No acute deliveryPersistent NRLight for gestational age Clinic‐Hospital (transport)
43232HDPSevere37 + 42116−2.01/57.20emCS (DD twin, PROM)NST during hospitalization25:4301:57Persistent NRLight for gestational age Hospital
53939PROMSevere39 + 231940.53/46.63VEG, FD (GH, NRFS)During labor02:1300:48Hon patternOthers Clinic
64040Onset of laborMild40 + 02430−1.93/47.02emCS (NRFS)During labor00:4200:12Reactive‐PDLight for gestational age Hospital
74040PROMSevere40 + 43160−0.11/2n/remCS (GH, NRFS)On admission49:5900:34Persistent NREclampsia Hospital
83939Onset of laborMild40 + 033260.60/1n/rVEG (NRFS)During labor02:1101:07Hon patternOthers Hospital
93840Oligohydramnios at pregnancy check upMild40 + 32594−1.51/3n/rVEG, emCS (umbilical cord prolapse)During labor00:5300:33Reactive‐PDUmbilical cord prolapse Hospital
103738HDPSevere38 + 52503−1.31/1n/remCS (Vasa previa, NRFS)During labor after ROM00:4800:39Reactive‐PDVasa previa Hospital
114141PROMSevere41 + 53250−0.22/66.89emCS (eclampsia)During labor01:2400:27Reactive‐PDEclampsia Clinic‐Hospital (transport)

BW, birth weight; CS, cesarean section; DD, dichorionic diamniotic; emCS, emergency CS; FD, forceps delivery; FHR, fetal heart rate; GA, gestational age; LD, late deceleration; MD, monochorionic diamniotic; NRFS, non‐reassuring fetal status; n/r, not reported; NSD, normal spontaneous delivery; PD, prolonged deceleration; PROM, premature rupture of membrane; SD, standard deviation; UApH, umbilical artery pH; VD, variable deceleration; VEG, vacuum extraction.

Summary of cases of cerebral palsy without placental abruption in HDP cases BW, birth weight; CS, cesarean section; DD, dichorionic diamniotic; emCS, emergency CS; FD, forceps delivery; FHR, fetal heart rate; GA, gestational age; LD, late deceleration; MD, monochorionic diamniotic; NRFS, non‐reassuring fetal status; n/r, not reported; NSD, normal spontaneous delivery; PD, prolonged deceleration; PROM, premature rupture of membrane; SD, standard deviation; UApH, umbilical artery pH; VD, variable deceleration; VEG, vacuum extraction.

Discussion

In our study, neonates with CP who weighed ≥ 2000 g at birth after at least 33 weeks’ gestation were more frequently terminated because of light‐for‐gestational age and placental abruption in women who suffered from HDP than in women without HDP. Furthermore, FHR pattern analysis showed bradycardia suspected long before admission may lead to CP from placental abruption in mothers of HDP. On the other hand, in women without placental abruption, the FHR pattern was likely to indicate a favorable fetal condition on admission, but FHR became worse, such as loss of baseline variability, late decelerations and prolonged decelerations, with the progression of labor. Impaired placentation, placental insufficiency, intrauterine hypoxia and uteroplacental underperfusion are considered important mechanisms causing placental abruption. 7, 8, 9, 10 In our study, infants of CP had been induced hypoxic condition because of persistent bradycardia in association with placental abruption in women with HDP. In fact, some pregnant women with HDP required maternal transport to a higher‐grade hospital to receive intensive care because of the occurrence of placental abruption. Even if placental abruption does not occur, because it is thought that conditions including HDP and fetal growth restriction associated with ischemic placental disease can originate during the first trimester, these may be linked through a unified pathophysiological mechanism. 11, 12 Contrary to CP with placental abruption in HDP, newborns with CP delivered by mothers with HDP without placental abruption were likely to be light‐for‐gestational age and were associated with a persistent non‐reassuring pattern on admission. In women without placental abruption, bradycardia and non‐reassuring fetal status at delivery were observed with the progression of labor in association with CP, while FHR pattern indicated a reassuring condition on admission. Such unfavorable conditions of hypoxia might have been induced by uteroplacental underperfusion with reduced placental function as a result of HDP and uterine contractions. Our results suggest that if a pregnant woman with HDP is at a hospital in which emergency cesarean section is not available, the patient should be immediately transferred to a tertiary hospital, even those with mild HDP. This will enable preparation of an acute delivery when progression to crucial conditions occurs, such as placental abruption or eclampsia. Additionally, caregivers in delivery services should perform FHR monitoring strictly in mothers with HDP because FHR is likely to worsen with the progression of labor, especially in growth‐restricted fetuses in women with HDP. Daily improvement of obstetric systems in hospitals, including suitable staffing and education and training for obstetric emergency personnel in HDP, is also required. Whether acute delivery can prevent CP after the occurrence of fetal growth restriction and placental abruption occurring in pregnant women with HDP is unclear. HDP is considered to be related to chronic uteroplacental underperfusion with its origin in the first trimester.11, 12 Therefore, in some cases of HDP, antepartum CP might already be present when placental abruption occurs. In fact, a persistent NR pattern on admission was observed in our case series with HDP. Although fetal and neonatal death was not evaluated in the present study, intensive care, even in cases of mild HDP, and preparation of immediate delivery will reduce the mortality rate associated with HDP. However, it is unclear whether the incidence of CP can be reduced. Furthermore, no fetal growth restriction was observed in women complicated with HDP and placental abruption in our study. This is because newborns with CP who were enrolled in the JOCSC weighed ≥ 2000 g after at least 33 weeks’ gestation. It is thought that newborns with CP were more frequently observed when delivered by mothers suffering severe HDP during earlier gestation. Further research on the management of severe fetal growth restriction and earlier HDP onset are needed. In conclusion, this large nationwide study shows that relevant obstetric factors for CP after 33 weeks’ gestation in association with HDP are light‐for‐gestational age and placental abruption. This is the first study to clinically demonstrate FHR patterns in CP cases in association with HDP. Most newborns with CP whose mothers suffer placental abruption already have fetal bradycardia when the mother is admitted to hospital. In cases without placental abruption, newborns were likely to be light‐for‐gestational age and FHR pattern was associated with a persistent non‐reassuring pattern on admission. Even in cases of a favorable FHR pattern on admission, FHR is likely to become worse with the progression of labor. Therefore, although detection of antepartum CP is impossible, pregnant women with HDP should be placed under strict observation, including maternal and fetal monitoring, to minimize fetal hypoxic conditions during labor.

Disclosure

No authors have any conflict of interest to report.

Author contributions

All authors have read and approved the final version of the manuscript.
  11 in total

1.  Placental abruption in term and preterm gestations: evidence for heterogeneity in clinical pathways.

Authors:  Cande V Ananth; Darios Getahun; Morgan R Peltier; John C Smulian
Journal:  Obstet Gynecol       Date:  2006-04       Impact factor: 7.661

2.  Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth.

Authors:  Cande V Ananth; Anthony M Vintzileos
Journal:  Am J Obstet Gynecol       Date:  2006-10-02       Impact factor: 8.661

3.  Etiologic determinants of abruptio placentae.

Authors:  M S Kramer; R H Usher; R Pollack; M Boyd; S Usher
Journal:  Obstet Gynecol       Date:  1997-02       Impact factor: 7.661

4.  Influence of hypertensive disorders and cigarette smoking on placental abruption and uterine bleeding during pregnancy.

Authors:  C V Ananth; D A Savitz; W A Bowes; E R Luther
Journal:  Br J Obstet Gynaecol       Date:  1997-05

5.  Fetal Heart Rate Observations in 300 Term Brain-damaged Infants

Authors: 
Journal:  J Matern Fetal Investig       Date:  1998-03

6.  A history of placental dysfunction and risk of placental abruption.

Authors:  S Rasmussen; L M Irgens; K Dalaker
Journal:  Paediatr Perinat Epidemiol       Date:  1999-01       Impact factor: 3.980

Review 7.  Hypertensive disease of pregnancy and maternal mortality.

Authors:  Jamie O Lo; John F Mission; Aaron B Caughey
Journal:  Curr Opin Obstet Gynecol       Date:  2013-04       Impact factor: 1.927

8.  Recurrence of ischemic placental disease.

Authors:  Cande V Ananth; Morgan R Peltier; Martin R Chavez; Russell S Kirby; Darios Getahun; Anthony M Vintzileos
Journal:  Obstet Gynecol       Date:  2007-07       Impact factor: 7.661

9.  Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States.

Authors:  Jun Zhang; Susan Meikle; Ann Trumble
Journal:  Hypertens Pregnancy       Date:  2003       Impact factor: 2.108

10.  Relevant Obstetric Factors for Cerebral Palsy: From the Nationwide Obstetric Compensation System in Japan.

Authors:  Junichi Hasegawa; Satoshi Toyokawa; Tsuyomu Ikenoue; Yuri Asano; Shoji Satoh; Tomoaki Ikeda; Kiyotake Ichizuka; Nanako Tamiya; Akihito Nakai; Keiya Fujimori; Tsugio Maeda; Hideaki Masuzaki; Hideaki Suzuki; Shigeru Ueda
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.